NASDAQ:SNGX Soligenix (SNGX) Stock Price, News & Analysis $4.53 +0.08 (+1.80%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$4.22▼$4.7050-Day Range$2.00▼$7.7352-Week Range$1.83▼$32.00Volume209,585 shsAverage Volume1.24 million shsMarket Capitalization$4.48 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Soligenix alerts: Email Address Soligenix MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestBearish38.71% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.44Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($9.20) to ($7.04) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.18 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Soligenix.Read more about Soligenix's stock forecast and price target. Previous Next 2.0 Short Interest Percentage of Shares Shorted38.71% of the float of Soligenix has been sold short.Short Interest Ratio / Days to CoverSoligenix has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Soligenix has recently increased by 1,836.04%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSoligenix does not currently pay a dividend.Dividend GrowthSoligenix does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SNGX. Previous Next 3.0 News and Social Media Coverage News SentimentSoligenix has a news sentiment score of 0.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Soligenix this week, compared to 1 article on an average week.Search Interest6 people have searched for SNGX on MarketBeat in the last 30 days. This is an increase of 20% compared to the previous 30 days.MarketBeat Follows4 people have added Soligenix to their MarketBeat watchlist in the last 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Soligenix insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.36% of the stock of Soligenix is held by insiders.Percentage Held by InstitutionsOnly 3.60% of the stock of Soligenix is held by institutions.Read more about Soligenix's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Soligenix are expected to grow in the coming year, from ($9.20) to ($7.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Soligenix is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Soligenix is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSoligenix has a P/B Ratio of 1.18. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Soligenix's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here About Soligenix Stock (NASDAQ:SNGX)Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has completed Phase III clinical trial for the treatment of cutaneous T-cell lymphoma; SGX942, an innate defense regulator technology that is in Phase III clinical trial for the treatment of inflammatory diseases, including oral mucositis in head and neck cancer; SGX302, an IDR technology which is in Phase IIa study to treat mil-to-moderate Psoriasis; and SGX945 and IDR technology that is in Phase IIa protocol for the treatment of Aphthous Ulcers in Behçet's Disease. The Public Health Solutions segment is involved in the development of RiVax, a ricin toxin vaccine candidate, which has completed Phase Ia, Ib, and Ic clinical trials; SGX943, a therapeutic candidate that is in pre-clinical stage for the treatment of antibiotic-resistant and emerging infectious diseases; ThermoVax, a technology in pre-clinical development for thermostabilizing vaccines; and CiVax, a vaccine candidate for the prevention of COVID-19. The company was formerly known as DOR BioPharma, Inc. and changed its name to Soligenix, Inc. in 2009. Soligenix, Inc. was incorporated in 1987 and is headquartered in Princeton, New Jersey.Read More SNGX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SNGX Stock News HeadlinesJuly 13, 2024 | marketbeat.comMarketBeat Week in Review – 7/8 - 7/12 (SNGX)Stocks took investors on quite a ride this week, with the S&P 500 hitting a new record high, then falling back on Thursday before rallying to end the weekJuly 10, 2024 | marketbeat.comUncover Why This Pharma Stock Jumped 400% on Study UpdateSoligenix Inc. NASDAQ: SNGX, a late-stage biopharmaceutical company, experienced an astonishing surge Tuesday. At the time of writing, the stock had soared nearly 400%.July 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.July 10, 2024 | marketbeat.comUncover Why This Pharma Stock Jumped 400% on Study UpdateShares of Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company, surged almost 400% today after announcing positive data.July 9, 2024 | investorplace.com5 Investors Betting Big on Soligenix (SNGX) StockJuly 9, 2024 | investorplace.comWhy Is Soligenix (SNGX) Stock Up 296% Today?July 9, 2024 | prnewswire.comExpanded HyBryte™ Treatment Demonstrating Positive Outcomes in Early-Stage Cutaneous T-Cell LymphomaJune 25, 2024 | prnewswire.comSoligenix Announces Positive Clinical Results from a Comparative Study Evaluating HyBryte™ Against Valchlor® in the Treatment of Cutaneous T-Cell LymphomaJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.June 14, 2024 | prnewswire.comA Comparison of Vaccine Technologies to be Presented at the ASM Microbe ConferenceMay 31, 2024 | prnewswire.comSoligenix Announces Reverse Stock SplitMay 29, 2024 | prnewswire.comSoligenix Encourages Stockholders to Vote their Shares at the Annual MeetingMay 24, 2024 | prnewswire.comSoligenix, Inc. Announces Adjournment of Annual Meeting, Information for Reconvened Annual MeetingMay 23, 2024 | prnewswire.comSoligenix Encourages Stockholders to Vote "FOR" Reverse Stock SplitMay 22, 2024 | finance.yahoo.comSoligenix, Inc. (SNGX)May 21, 2024 | finance.yahoo.comPRISM MarketView Highlights Soligenix, Inc. as it Builds on Compelling Phase 3 Data with Key Catalysts on the HorizonMay 21, 2024 | prnewswire.comSuVax™ and MarVax™ Thermostable Vaccine Platform to be Presented at the Vaccine Technology IX ConferenceMay 20, 2024 | prnewswire.comSoligenix Encourages Stockholders to Vote Prior to Annual MeetingSee More Headlines Receive SNGX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Soligenix and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/10/2024Today7/26/2024Next Earnings (Estimated)8/19/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:SNGX CUSIPN/A CIK812796 Webwww.soligenix.com Phone(609) 538-8200Fax609-452-6467Employees13Year Founded1987Profitability EPS (Most Recent Fiscal Year)($11.52) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,140,000.00 Net Margins-1,025.66% Pretax Margin-1,116.86% Return on Equity-198.36% Return on Assets-61.43% Debt Debt-to-Equity RatioN/A Current Ratio1.08 Quick Ratio1.08 Sales & Book Value Annual Sales$840,000.00 Price / Sales5.34 Cash FlowN/A Price / Cash FlowN/A Book Value$3.83 per share Price / Book1.18Miscellaneous Outstanding Shares990,000Free Float974,000Market Cap$4.48 million OptionableNot Optionable Beta1.88 Social Links 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesDr. Christopher J. Schaber Ph.D. (Age 58)Chairman of the Board of Directors, CEO & President Comp: $625kMr. Jonathan L. Guarino CPA (Age 51)CGMA, Senior VP, CFO & Corporate Secretary Comp: $309.4kDr. Oreola Donini Ph.D. (Age 52)Senior VP & Chief Scientific Officer Comp: $342.31kDr. Richard C. Straube M.D. (Age 72)MSc., Senior VP & Chief Medical Officer Comp: $212.2kKey CompetitorsGain TherapeuticsNASDAQ:GANXJanOneNASDAQ:JANKALA BIONASDAQ:KALAGlycoMimeticsNASDAQ:GLYCiBioNYSE:IBIOView All CompetitorsInstitutional OwnershipOLD National Bancorp INBought 10,000 shares on 7/11/2024Ownership: 1.010%View All Institutional Transactions SNGX Stock Analysis - Frequently Asked Questions How have SNGX shares performed this year? Soligenix's stock was trading at $12.1152 on January 1st, 2024. Since then, SNGX shares have decreased by 62.6% and is now trading at $4.53. View the best growth stocks for 2024 here. How were Soligenix's earnings last quarter? Soligenix, Inc. (NASDAQ:SNGX) released its quarterly earnings data on Friday, May, 10th. The biopharmaceutical company reported ($2.88) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($3.20) by $0.32. The biopharmaceutical company earned $0.10 million during the quarter, compared to analyst estimates of $0.20 million. Soligenix had a negative trailing twelve-month return on equity of 198.36% and a negative net margin of 1,025.66%. When did Soligenix's stock split? Soligenix's stock reverse split on Thursday, June 6th 2024. The 1-16 reverse split was announced on Thursday, June 6th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, June 6th 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split. Who are Soligenix's major shareholders? Soligenix's top institutional shareholders include OLD National Bancorp IN (1.01%). Insiders that own company stock include Christopher J Schaber, Richard Straube and Jonathan L Guarino. View institutional ownership trends. How do I buy shares of Soligenix? Shares of SNGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Soligenix own? Based on aggregate information from My MarketBeat watchlists, some other companies that Soligenix investors own include VBI Vaccines (VBIV), T2 Biosystems (TTOO), Trevena (TRVN), Vaxart (VXRT), OPKO Health (OPK), SCYNEXIS (SCYX) and Dynavax Technologies (DVAX). This page (NASDAQ:SNGX) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soligenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Soligenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
